DSIP

What it is (in plain language)
- It's not an ordinary sedative that 'turns you off'. DSIP helps the brain enter the deepest, most restorative phase of sleep. It also acts as a stress regulator, helping to balance cortisol levels and the production of LH (luteinising hormone).

Why do you appear online so much
- It's the go-to solution for severe insomnia and for those living under chronic high stress. It is valued because it does not cause dependence on conventional drugs and improves the quality of rest rather than just inducing unconsciousness.

How it is framed today (pragmatic view)
- 1) Evidence: Decades of study in Russia and Europe focusing on sleep disorders and withdrawal. 2) Objective: Restoration of the circadian cycle and reduction of anxiety. 3) Risk: Very variable individual response; some people feel immediate effects, others need cumulative use.

How to use this form
- Check the night administration protocols in the 'Handling Notes' section.

- Quick profile (curated by Subject 157)
- Class: Nootropic
- Status: Verified
- Use case: Nootropic
- Route: Injectable
- Tags: Injectable|Sleep|Recovery
- Half-life: ~4-5 Mins (Plasma)
- Start: 30-60 mins
- Duration: Variable

- Mechanism (high level)
Endogenous neuromodulator (nonapeptide). Modulates NMDA receptors and the GABAergic system, promoting slow-wave sleep (Delta) and normalising circadian rhythms.

- Evidence (what the literature covers)
RESEARCH RANGE (Non-prescriptive):
Studied in doses of 100mcg (IV/SC).
Level of Evidence: C.

- Safety and harm-reduction (non-prescriptive)
Risks: Daytime sleepiness if taken incorrectly.
Interactions: Sedatives.

- References (anchors)
- Kovalzon, V. M. (2006) - DSIP and regulation of sleep-wake states - https://doi.org/10.1111/j.1471-4159.2006.03693.x | PubMed:16539665
- Sudakov, S. K. (2001) - DSIP and stress-related neuroendocrine modulation - https://doi.org/10.3109/10253890109115728 | PubMed:11824905

Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.